MigraineMind research summary
Migraine Headaches in a Pediatric Patient With SETD5-Related Neurodevelopmental Disorder and Inflammatory Comorbidities: A Case Report.
Cureus | 2026
Case report / case seriesSummary
This research discusses a rare genetic condition called SETD5-related neurodevelopmental disorder. It affects children and is linked to a mutation in the SETD5 gene. This condition can cause intellectual disability, behavioral challenges, and physical health issues. The case report focuses on an eight-year-old boy with SETD5 and inflammatory conditions. He experienced severe migraines with symptoms like light sensitivity and nausea. His headaches were so intense they woke him from sleep. The only medication that helped him was rizatriptan. This case is significant because migraine headaches have not been previously linked to SETD5-related disorders. By sharing this information, the researchers aim to expand understanding of SETD5 and its potential health effects. This could help doctors recognize and treat similar cases in other children with this genetic condition, improving their quality of life and headache management. Clinical relevance: This report highlights the need for awareness of migraines in children with SETD5-related disorders.
Key Learning Points
- SETD5-related neurodevelopmental disorder is a rare genetic condition that can lead to intellectual disability and behavioral challenges in children.
- Children with SETD5 may experience physical health issues, including severe migraines that can disrupt their sleep.
- Migraine headaches in patients with SETD5 have not been previously documented, highlighting the need for increased awareness among healthcare providers.
- Rizatriptan was effective in managing the migraines of an eight-year-old boy with SETD5, suggesting potential treatment options for similar cases.
- Understanding the health effects of SETD5 can improve diagnosis and treatment strategies, enhancing the quality of life for affected children.
Original research
Read the original publication and review its full methods and findings on PubMed.
MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.